GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » 3-Year ROIIC %

Obio Technology (shanghai) (SHSE:688238) 3-Year ROIIC % : -12.20% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Obio Technology (shanghai) 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Obio Technology (shanghai)'s 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -12.20%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Obio Technology (shanghai)'s 3-Year ROIIC % or its related term are showing as below:

SHSE:688238's 3-Year ROIIC % is ranked better than
50.96% of 1358 companies
in the Biotechnology industry
Industry Median: -13.43 vs SHSE:688238: -12.20

Obio Technology (shanghai) 3-Year ROIIC % Historical Data

The historical data trend for Obio Technology (shanghai)'s 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obio Technology (shanghai) 3-Year ROIIC % Chart

Obio Technology (shanghai) Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial - - 18.12 5.78 -12.20

Obio Technology (shanghai) Quarterly Data
Dec18 Jun19 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -12.20 - - -

Competitive Comparison of Obio Technology (shanghai)'s 3-Year ROIIC %

For the Biotechnology subindustry, Obio Technology (shanghai)'s 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Obio Technology (shanghai)'s 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Obio Technology (shanghai)'s 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Obio Technology (shanghai)'s 3-Year ROIIC % falls into.



Obio Technology (shanghai) 3-Year ROIIC % Calculation

Obio Technology (shanghai)'s 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -128.3240364 (Dec. 2023) - 19.1514176 (Dec. 2020) )/( 1731.568 (Dec. 2023) - 523.026 (Dec. 2020) )
=-147.475454/1208.542
=-12.20%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Obio Technology (shanghai)  (SHSE:688238) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Obio Technology (shanghai) 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Obio Technology (shanghai)'s 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Obio Technology (shanghai) Business Description

Traded in Other Exchanges
N/A
Address
Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201318
Obio Technology (shanghai) Corp Ltd is a biotechnology company focusing on the field of gene therapy, focusing on the development of gene therapy vectors, gene function research, drug targets and efficacy for the basic research of gene therapy Research and other CRO services, and provide CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
Executives
You Qing Rui Directors, senior managers
Pan Jun Yi Director
Yang Jia Li Core technical personnel

Obio Technology (shanghai) Headlines

No Headlines